reported to be related to the prognosis of various cancers. [1] [2] [3] [4] Many studies have also confirmed that they are related to the progression and prognosis of many other diseases, like cardiovascular diseases, 10, 11 virus infectious diseases 12, 13 and thrombosis-related diseases.
14,15
What's more, a novel index, defined as the systemic immuneinflammation index (SII), based on lymphocyte, neutrophil and platelet counts, has been developed recently. Bo Hu and his colleagues find that the SII is a promising independent predictive factor for prognosis of patients with hepatocellular carcinoma (HCC) after surgery. 5 And it also has been proven to be related with gastric cancer, 16 metastatic castration-resistant prostate cancer (mCRPC), 17 small cell lung cancer 18 and esophageal squamous cell carcinoma. 19 But 
| MATERIALS AND METHODS

| Inclusion and exclusion of subjects
A retrospective analysis in the database of the laboratory information system (LIS) and the hospital information system (HIS) of the First Affiliated Hospital of Zhengzhou University to retrieve results of hematological testing performed on a cohort of ostensibly healthy, aged no <18 years old physical examinees who took health examination from January to December in 2013, which had been described before, 20 was implemented. This study was approved by the ethics committee of the First Affiliated Hospital of Zhengzhou University.
Subjects with HBV, HCV, HIV or any other diagnosed virus infection, autoimmune diseases such as systemic lupus erythematosus (SLE), leukemia or any other blood system diseases, or any other organic disease (liver, spleen, et al.) were excluded; Subjects receiving the treatment of whole blood or any other component blood products transfusion were also excluded. Subects aged no <18 year-old and with eligible blood sample were included and analyzed.
Subjects' inclusion and exclusion were conducted as flowchart showed: 
| Clinical data
| Statistics
The statistical analysis was performed using IBM SPSS Statistics ver- 
| RESULTS
| General characteristics of main hematological parameters of 24 029 included subjects
As shown in the flowchart (Figure 1 ), 24 029 subjects in total, a cohort that were aged no <18 years old (18-65 year-old (adulets) or more than 65 year-old (old-adults)), ostensibly healthy, were finally included.
Here, since the SII, PLR, NLR, LMR and MLR were calculated based on PLT, Neo, Lymph and Mo, we excluded subjects with any WBC, Tables 1 and 2. What's more, the reason for Tukey's (1977) rule, but not the D/R rule, was being used was that on a big-data basis, values of each hematological parameters were closed leading to a relatively small 'D' while ranges of them were large leading to a relatively big 'R', which gave rise to none outlier observed and with a big sample size distribution of all parameters can be considered normal. T A B L E 1 General characteristics of main hematological parameters of 24 029 included subjects based on gender each parameter and each stratification after eliminating outliers was counted as RIs (Table 5 ).
| Influences of gender and age on SII, PLR, NLR, LMR and MLR
| Validation of reference intervals of SII, PLR, NLR, LMR and MLR
On the bases of Clinical and Laboratory Standards Institute (CLSI) document C28-A3, we further included a cohort of 450 healthy persons to validate the reference intervals of SII, PLR, NLR, LMR and MLR.
For SII (without stratification), PLR (with stratification for age), NLR (with stratification for both age and gender), LMR (with stratification for both age and gender) and MLR (with stratification for both age and gender), proportions of outsiders which are validation values below or beyond established RIs are all <10% (Table 6 ), which means RIs of SII, PLR, NLR, LMR and MLR are efficient and successfully established. there are also limitations to this study that should be emphasized.
| DISCUSSION
First, as the C28-A3 mainly recommend rules of RIs establishing that meet the minimum requirements for reliability and usefulness (like for the minimum sample number asked), 21 there is a lack of rules for RI establishing on a big-data bassis and we adopt a plausible method as far as possible in accordance with the C28-A3. Second, only adults aged no <18 are analyzed and only age and gender are pondered for strat- experimental design of the related studies and lead to better standardizations of SII, PLR, NLR, LMR and MLR for their clinical applications.
